Association of serum Asprosin concentrations with heart failure

Background: To analyze the association of serum Asprosin concentrations with heart failure (HF). Methods: A total of 103 patients with HF were included in the HF group, and 103 patients with health checkups were included in the non-HF group. The serum Asprosin levels of the two groups were measured, and relevant clinical data were collected for statistical analysis. Results: Compared with the non-HF group, the serum Asprosin concentration was significantly higher in the HF group, and the difference was statistically significant ( P <0.001). According to the serum Asprosin levels, we divided all the subjects into three quartiles. We found that the prevalence of HF increased with increasing serum Asprosin levels in the three groups ( P <0.001). Serum Asprosin levels were positively correlated with NT-ProBNP ( P <0.05) and negatively correlated with LVEF ( P <0.001). Dichotomous logistic regression analysis found Asprosin to be an independent risk factor for HF (OR =1.010, 95% CI: 1.003-1.018). Combining Asprosin and NT-proBNP indicators to draw ROC curves can improve the specificity and sensitivity of HF diagnosis. Conclusions: Serum Asprosin levels were significantly elevated in HF patients. The serum Asprosin level is an independent risk factor for HF, and the combined detection of Asprosin and NT-proBNP levels can improve the accuracy of HF diagnosis.